Image: ASCENSIA LAND LOGO HORIZONTAL
For Healthcare Professionals
  • Blood Glucose Monitoring
  • Blood Glucose Monitoring
  • Continuous Glucose Monitoring
  • Continuous Glucose Monitoring
  • About Us
  • About Us
  • Support
  • Support
Magnifier Glass Search Icon
hamburger menu
  • Blood Glucose Monitoring
  • Blood Glucose Monitoring
  • Continuous Glucose Monitoring
  • Continuous Glucose Monitoring
  • About Us
  • About Us
  • Support
  • Support
  • For Healthcare Professionals
Image: ASCENSIA LAND LOGO HORIZONTAL
Contour Logo

Blood Glucose Monitoring

Eversense Logo

Continuous Glucose Monitoring System

 

About Ascensia Diabetes Care

Ascensia Diabetes Care is a global company behind the trusted CONTOUR® blood glucose monitoring systems and the exclusive worldwide distribution partner for Eversense® continuous glucose monitoring systems from Senseonics.

Ascensia 80 Years Badge
BGM Devices

CONTOUR® Blood Glucose Monitoring

Rely on the trusted CONTOUR® blood glucose monitoring systems for your diabetes management.

 

Eversense 365 Continuous Glucose Monitoring System

Introducing Eversense 365. The only CGM that lasts a year.

 
Eversense CGM

Partners


Proud Supporters Of

JDRF American Diabetes Association ADCES Diabetes Foundation
Footer Logo

Contact

Ascensia Diabetes Care
5 Wood Hollow Road
Parsippany
NJ 07054
United States

1-800-348-8100 (CONTOUR Blood Glucose Monitoring)
1-844-736-7348 (Eversense Continuous Glucose Monitoring)

Legal

  • About Us
  • Contact Us
  • Press
  • Ascensia Conditions of Use
  • Ascensia Privacy & Cookies Statement
  • Consumer Health Privacy Policy
  • Eversense EULA
  • Eversense Privacy Policy
  • Eversense Legal and Warranty
  • Eversense Patents
  • Distributors
  • Contour Phone Compatibility List
  • Report a Compliance Incident
  • Cookie Settings

©2025 Ascensia Diabetes Care Holdings AG. All rights reserved.
©2025 Senseonics, Inc. All rights reserved.

The Eversense® 365 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to one year in people (18 years and older) with diabetes. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are required for calibration one time a week after day 13, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense 365 CGM System is a prescription device; patients should talk to their health care provider to learn more.

For important safety information, see bit.ly/eversensesafety

Eversense, Eversense 365 Continuous Glucose Monitoring, and the Eversense logo are trademarks of Senseonics, Incorporated. Ascensia, the Ascensia Diabetes Care logo are trademarks and/or registered trademarks of Ascensia Diabetes Care Holdings AG. All other trademarks are properties of their respective owners and are used solely for informative purposes. No relationship or endorsement should be inferred or implied.


Apple Watch® is a product of Apple, Inc., and may be separately purchased from an authorized Apple retailer. Apple Watch is not included with the Eversense CGM System. Android is a trademark of Google LLC.